The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Cited by
Items 701–800 of 1,072
CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context
Corsi, G. I., Qu, K., Alkan, F., Pan, X., Luo, Y., & Gorodkin, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30515-0 · Cited by 99
“Viral titre was estimated by counting the number of GFP-positive cells in the virus-treated population by flow cytometry (FCM) as follows: (1) HEK293T cells were split and seeded to a 24-well plate on day 1.”
MethodAI-driven business analytics and decision making
Badmus, O., Rajput, S. A., Arogundade, J. B., & Williams, M. (2024) · World Journal of Advanced Research and Reviews · doi:10.30574/wjarr.2024.24.1.3093 · Cited by 103
CRISPR engineering in organoids for gene repair and disease modelling
Geurts, M. H., & Clevers, H. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00013-5 · Cited by 103
Wu, W., Lu, Z., Li, F., Wang, W., Qian, N., Duan, J., Zhang, Y., Wang, F., & Chen, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614775114 · Cited by 99
Patterned cell and matrix dynamics in branching morphogenesis
Wang, S., Sekiguchi, R., Daley, W. P., & Yamada, K. M. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610048 · Cited by 105
Generation and Applications of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells
Zhao, C., & Ikeya, M. (2018) · Stem Cells International · doi:10.1155/2018/9601623 · Cited by 107
“PSCs are also compatible with gene-directed enzyme prodrug therapy (GDEPT) or CRISPR/Cas9 and related technologies [5, 6] for gene editing.”
CRISPR-directed mitotic recombination enables genetic mapping without crosses
Sadhu, M. J., Bloom, J. S., Day, L., & Kruglyak, L. (2016) · Science · doi:10.1126/science.aaf5124 · Cited by 113
Ju, E., Li, T., da Silva, S. R., & Gao, S. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12335 · Cited by 108
Prime editing with genuine Cas9 nickases minimizes unwanted indels
Lee, J., Lim, K., Kim, A., Mok, Y. G., Chung, E., Cho, S.-I., Lee, J. M., & Kim, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37507-8 · Cited by 116
Park, H., Jo, S. H., Lee, R. H., Macks, C. P., Ku, T., Park, J., Lee, C. W., Hur, J. K., & Sohn, C. H. (2023) · Advanced Science · doi:10.1002/advs.202206939 · Cited by 115
Vitek, M. P., Araujo, J. A., Fossel, M., Greenberg, B. D., Howell, G. R., Rizzo, S. J. S., Seyfried, N. T., Tenner, A. J., Territo, P. R., Windisch, M., et al. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12114 · Cited by 103
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b
El Fatimy, R., Subramanian, S., Uhlmann, E. J., & Krichevsky, A. M. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.004 · Cited by 97
Emerging roles for R-loop structures in the management of topological stress
Chedin, F., & Benham, C. J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006364 · Cited by 98
“Such invasion typically requires protein-mediated catalysis, either by components of the homology-directed DNA recombination machinery (70, 71) or by CRISPR-Cas systems (72, 73).”
BackgroundTimed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair
Wienert, B., Nguyen, D. N., Guenther, A., Feng, S. J., Locke, M. N., Wyman, S. K., Shin, J., Kazane, K. R., Gregory, G. L., Carter, M. A. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15845-1 · Cited by 108
Liu, M.-S., Gong, S., Yu, H.-H., Jung, K., Johnson, K. A., & Taylor, D. W. (2020) · Nature Communications · doi:10.1038/s41467-020-17411-1 · Cited by 95
RNA chemistry and therapeutics
Wang, S., Weissman, D., & Dong, Y. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01237-x · Cited by 118
“These guide RNAs contain sequence elements that enable binding to the Cas proteins and target DNA or RNA 339,340 .”
Himeda, C. L., Jones, T. I., & Jones, P. L. (2015) · Molecular Therapy · doi:10.1038/mt.2015.200 · Cited by 113
Eppig, J. T. (2017) · ILAR Journal · doi:10.1093/ilar/ilx013 · Cited by 103
Editing policy to fit the genome?
Isasi, R., Kleiderman, E., & Knoppers, B. M. (2016) · Science · doi:10.1126/science.aad6778 · Cited by 101
Lin, J., Zhang, Z., Zhang, S., Chen, J., & Wong, K. (2020) · Advanced Science · doi:10.1002/advs.201903562 · Cited by 101
The Cpf1 CRISPR-Cas protein expands genome-editing tools
Fagerlund, R. D., Staals, R. H. J., & Fineran, P. C. (2015) · Genome Biology · doi:10.1186/s13059-015-0824-9 · Cited by 95
“In the past three years, immense academic and commercial interest has pushed the technology from a concept to a widely used molecular biology tool [3].”
InfluentialThe commercialization of genome-editing technologies
Brinegar, K., K. Yetisen, A., Choi, S., Vallillo, E., Ruiz-Esparza, G. U., Prabhakar, A. M., Khademhosseini, A., & Yun, S.-H. (2017) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2016.1271768 · Cited by 77
“However, these technologies have had limited use due to design complexity, transfection inefficiencies and limitations in multiplexed mutations [3].”
BackgroundTingley, R., Ward‐Fear, G., Schwarzkopf, L., Greenlees, M., Phillips, B. L., Brown, G. P., Clulow, S., Webb, J. K., Capon, R. J., SHEPPARD, A. W., et al. (2017) · The Quarterly Review of Biology · doi:10.1086/692167 · Cited by 102
Promises and challenges in insect–plant interactions
Giron, D., Dubreuil, G., Bennett, A. E., Dedeine, F., Dicke, M., Dyer, L. A., Erb, M., Harris, M. O., Huguet, E., Kaloshian, I., et al. (2018) · Entomologia Experimentalis et Applicata · doi:10.1111/eea.12679 · Cited by 108
“Recent advances in the use of CRISPR-Cas9, a new gene-editing technology (Doudna & Charpentier, 2014), or exogenous application onto plants of herbivore-targeted double stranded RNA, similar to that used for plant pathogens, may provide future solutions (Wang & Jin, 2016; Sun et al., 2017).”
BackgroundMethodMollanoori, H., Shahraki, H., Rahmati, Y., & Teimourian, S. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.09.007 · Cited by 110
Kausch, A. P., Nelson‐Vasilchik, K., Hague, J. P., Mookkan, M., Quemada, H. D., Dellaporta, S. L., Fragoso, C., & Zhang, Z. J. (2019) · Plant Science · doi:10.1016/j.plantsci.2019.01.006 · Cited by 110
Jo, D. H., Song, D. W., Cho, C. S., Kim, U. G., Lee, K. J., Lee, K., Park, S. W., Kim, D., Kim, J. H., Kim, J.-S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aax1210 · Cited by 102
All‐In‐One Dendrimer‐Based Lipid Nanoparticles Enable Precise HDR‐Mediated Gene Editing In Vivo
Farbiak, L., Cheng, Q., Wei, T., Álvarez‐Benedicto, E., Johnson, L. T., Lee, S. M., & Siegwart, D. J. (2021) · Advanced Materials · doi:10.1002/adma.202006619 · Cited by 108
IRF3 activates RB to authorize cGAS-STING–induced senescence and mitigate liver fibrosis
Wu, Q., Leng, X., Zhang, Q., Zhu, Y., Zhou, R., Liu, Y., Chen, M., Zhang, D., Liu, S., Chen, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adj2102 · Cited by 115
Achieving Plant CRISPR Targeting that Limits Off‐Target Effects
Wolt, J. D., Wang, K., Sashital, D., & Lawrence‐Dill, C. J. (2016) · The Plant Genome · doi:10.3835/plantgenome2016.05.0047 · Cited by 93
Highly Efficient CRISPR/HDR-Mediated Knock-in for Mouse Embryonic Stem Cells And Zygotes
Wang, B., Li, K., Wang, A., Reiser, M., Saunders, T., Lockey, R. F., & Wang, J.-W. (2015) · BioTechniques · doi:10.2144/000114339 · Cited by 95
Skipping Multiple Exons to Treat DMD—Promises and Challenges
Aslesh, T., Maruyama, R., & Yokota, T. (2018) · Biomedicines · doi:10.3390/biomedicines6010001 · Cited by 104
“However, one of the potential issues with the use of CRISPR/Cas9 system includes the occurrence of off-target cleavage [69].”
BackgroundAn overview of treatment strategies for Hutchinson-Gilford Progeria syndrome
Harhouri, K., Frankel, D., Bartoli, C., Roll, P., Sandre‐Giovannoli, A. D., & Lévy, N. (2018) · Nucleus · doi:10.1080/19491034.2018.1460045 · Cited by 105
Kato-Inui, T., Takahashi, G., Hsu, S., & Miyaoka, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky264 · Cited by 108
“In general, CRISPR/Cas9 is very efficient at inducing NHEJ and has already been established as an excellent tool for knocking-out genes in various species (13).”
VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells
English, J. G., Olsen, R. H. J., Lansu, K., Patel, M., White, K., Cockrell, A. S., Singh, D., Strachan, R. T., Wacker, D., & Roth, B. L. (2019) · Cell · doi:10.1016/j.cell.2019.05.051 · Cited by 108
“High value targets would include: Cas9 variants evolved to better engage endogenous sequences (Doudna and Charpentier, 2014; Kleinstiver et al., 2015; Lee et al., 2018), fluorescent protein variants evolved for maturity time, photostability, brightness, or wavelength specificity in human tissue…”
BackgroundWannier, T. M., Ciaccia, P. N., Ellington, A. D., Filsinger, G. T., Isaacs, F. J., Javanmardi, K., Jones, M. A., Kunjapur, A. M., Nyerges, Á., Pál, C., et al. (2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00006-x · Cited by 110
Lipid Nanoparticle Spherical Nucleic Acids for Intracellular DNA and RNA Delivery
Sinegra, A. J., Evangelopoulos, M., Park, J., Huang, Z. N., & Mirkin, C. A. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c01973 · Cited by 100
Multiplexed genome regulation in vivo with hyper-efficient Cas12a
Guo, L. Y., Bian, J., Davis, A. E., Liu, P., Kempton, H. R., Zhang, X., Chemparathy, A., Gu, B., Lin, X., Rane, D. A., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00870-7 · Cited by 95
CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection
Gong, S., Zhang, S., Lü, F., Pan, W., Li, N., & Tang, B. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02533 · Cited by 105
Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus
Sutton, T. C., & Subbarao, K. (2015) · Virology · doi:10.1016/j.virol.2015.02.030 · Cited by 96
“Transgenic mice could be generated via traditional methods or using the CRISPR–Cas9 (Doudna and Charpentier, 2014) system to replace mouse DPP4 with human DPP4 or to introduce a mouse DPP4 carrying the mutations that promote S protein binding.”
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side
Hudecek, M., Izsvák, Z., Johnen, S., Renner, M., Thumann, G., & Ivics, Z. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1304354 · Cited by 92
“Designer nucleases, including zinc finger nucleases (ZFNs), transcription activator like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)/Cas nucleases are excellent tools for genome engineering and gene editing (Doudna & Charpentier, 2014).”
DeMayo, F. J., & Lydon, J. P. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0212 · Cited by 110
“With the advent of precise Crispr/Cas9 gene editing (Doudna and Charpentier 2014), high-resolution structure functional analysis is now possible in vivo not only for the PGR but also for its mediators and modulators.”
Chen, Q., Zhang, Y., & Yin, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.014 · Cited by 104
Proteins from the DNA Damage Response: Regulation, Dysfunction, and Anticancer Strategies
Molinaro, C., Martoriati, A., & Cailliau, K. (2021) · Cancers · doi:10.3390/cancers13153819 · Cited by 104
Green, C. M., Spangler, J. R., Susumu, K., Stenger, D. A., Medintz, I. L., & Dı́az, S. A. (2022) · ACS Nano · doi:10.1021/acsnano.2c07749 · Cited by 99
Coupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices
Koonin, E. V., & Zhang, F. (2017) · BioEssays · doi:10.1002/bies.201600186 · Cited by 101
Dual RNA-Sequencing to Elucidate the Plant-Pathogen Duel
Naidoo, S., Visser, E. A., Zwart, L., du Toit, Y., Bhadauria, V., & Shuey, L. S. (2017) · Current Issues in Molecular Biology · doi:10.21775/cimb.027.127 · Cited by 111
Yu, S., Yao, Y., Xiao, H., Li, J., Liu, Q., Yang, Y., Adah, D., Lu, J., Zhao, S., Qin, L., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.032 · Cited by 95
“Recently, the CRISPR/Cas9 system has been modified to fit various research fields from genetic engineering to transcriptional modulation, 24 which significantly improves the development of translational medicine.”
Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae
Basgall, E. M., Goetting, S. C., Goeckel, M. E., Giersch, R. M., Roggenkamp, E., Schrock, M. N., Halloran, M., & Finnigan, G. C. (2018) · Microbiology · doi:10.1099/mic.0.000635 · Cited by 107
“The recent discovery of the clustered regularly interspaced short palindromic repeats (CRISPR) system in prokaryotes [1] has led to a major shift in many fields of molecular biology and biotechnology [2 – 4].”
Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis
Velino, C., Carella, F., Adamiano, A., Sanguinetti, M., Vitali, A., Catalucci, D., Bugli, F., & Iafisco, M. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00406 · Cited by 104
Kim, S., Ji, S., & Koh, H. R. (2021) · Biomolecules · doi:10.3390/biom11081162 · Cited by 110
“These methods mostly use the deactivated Cas9 (dCas9) proteins where the dsDNA cleavage activity is eliminated by changing two amino acids in each cleavage-responsible domain of the Cas9 proteins, RuvC and HNH, displaying the strong binding affinity to dsDNA [9,10].”
MethodChen, Y., Chen, Z., Li, T., Qiu, M., Zhang, J., Wang, Y., Yuan, W., Ho, H., Al‐Hartomy, O. A., Wageh, S., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c05007 · Cited by 98
CRISPR/dCas9‐Mediated Multiplex Gene Repression in Streptomyces
Zhao, Y., Li, L., Zheng, G., Jiang, W., Deng, Z., Wang, Z., & Lü, Y. (2018) · Biotechnology Journal · doi:10.1002/biot.201800121 · Cited by 102
Defining CRISPR–Cas9 genome-wide nuclease activities with CIRCLE-seq
Lazzarotto, C. R., Nguyen, N. T., Tang, X., Malagon-Lopez, J., Guo, J. A., Aryee, M. J., Joung, J. K., & Tsai, S. Q. (2018) · Nature Protocols · doi:10.1038/s41596-018-0055-0 · Cited by 96
A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing
Saber Sichani, A., Ranjbar, M., Baneshi, M., Torabi Zadeh, F., & Fallahi, J. (2023) · Molecular Biotechnology · doi:10.1007/s12033-022-00639-1 · Cited by 97
“The CRISPR/ Cas system awarded its developers the Noble Prize influencing the world of molecular biology and medicine [1].”
BackgroundStrategies to enhance CAR-T persistence
Liu, Y., An, L., Huang, R., Xiong, J., Yang, H., Wang, X., & Zhang, X. (2022) · Biomarker Research · doi:10.1186/s40364-022-00434-9 · Cited by 97
“In particular, the clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 9 (CRISPR/Cas9) system is considered the next generation of genomic editing technology and it has been widely applied [140].”
BackgroundGenome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System
Wang, S., Dong, S., Wang, P., Tao, Y., & Wang, Y. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.00233-17 · Cited by 107
Effective PEI-mediated delivery of CRISPR-Cas9 complex for targeted gene therapy
Ryu, N., Kim, M.-A., Park, D., Lee, B., Kim, Y., Kim, K., Baek, J., Kim, W. J., Lee, K.-Y., & Kim, U. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.06.009 · Cited by 97
Advancements in clinical RNA therapeutics: Present developments and prospective outlooks
Saw, P. E., & Song, E. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101555 · Cited by 112
Long-term expansion and differentiation of adult murine epidermal stem cells in 3D organoid cultures
Boonekamp, K. E., Kretzschmar, K., Wiener, D. J., Asra, P., Derakhshan, S., Puschhof, J., López-Iglesias, C., Peters, P. J., Basak, O., & Clevers, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715272116 · Cited by 96
“CRISPR−Cas9 genome editing is an elegant and efficient way to introduce genetic alterations into mammalian cells (48).”
BackgroundEngineered polyketides: Synergy between protein and host level engineering
Barajas, J. F., Blake-Hedges, J. M., Bailey, C. B., Curran, S., & Keasling, J. D. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.08.005 · Cited by 102
“The increasing promise of the CRISPR-Cas9 system for rapid and targeted genetic manipulations [191,192] has led to the development of protocols for using the technique in natural productproducing bacteria such as Streptomyces.”
BackgroundEmerging Opportunities for Synthetic Biology in Agriculture
Goold, H. D., Wright, P., & Hailstones, D. (2018) · Genes · doi:10.3390/genes9070341 · Cited by 106
“These projects and other developments such as CRISPR/Cas9-mediated gene editing have enabled myriad, previously impossible tasks to become not only feasible but relatively simple [5,6].”
BackgroundDIPA-CRISPR is a simple and accessible method for insect gene editing
Shirai, Y., Piulachs, M., Bellés, X., & Daimon, T. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100215 · Cited by 109
Gene Targeting Differential Evolution: A Simple and Efficient Method for Large-Scale Optimization
Wang, Z., Jian, J.-R., Zhan, Z., Li, Y., Kwong, S., & Zhang, J. (2022) · IEEE Transactions on Evolutionary Computation · doi:10.1109/tevc.2022.3185665 · Cited by 96
“In 2020, Doudna and Charpentier won the Nobel Prize in Chemistry for their contributions in clustered regularly interspaced short palindromic repeats (CRISPR/Cas9) gene editing [34].”
BackgroundAhmadi, S. E., Soleymani, M., Shahriyary, F., Amirzargar, M. R., Mahya, O., Fattahi, D., & Safa, M. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00597-z · Cited by 103
“CRISPR/Cas is originally a system for defending bacteria against invaders, which is now being used for gene editing in mammalian cells and is able to provide immunity that transcends bacterial boundaries [31, 32].”
BackgroundUnderstanding Celiac Disease by Genomics
Withoff, S., Li, Y., Jonkers, I. H., & Wijmenga, C. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.02.003 · Cited by 108
Wang, Y., Wei, D., Zhu, X., Pan, J., Zhang, P., Huo, L., & Zhu, X. (2016) · Scientific Reports · doi:10.1038/srep31145 · Cited by 102
Mouridi, S. E., Lecroisey, C., Tardy, P., Mercier, M., Leclercq-Blondel, A., Zariohi, N., & Boulin, T. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.040824 · Cited by 104
“The pace of technical developmentsallowingthe directmanipulation of genome sequences has seen a marked acceleration in recent years with the emergence of RNA-targeted nucleases derived from bacterial immune systems (Doudna and Charpentier 2014; Zetsche et al. 2015).”
A CRISPR New World: Attitudes in the Public toward Innovations in Human Genetic Modification
Weisberg, S. M., Badgio, D., & Chatterjee, A. K. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00117 · Cited by 96
“There was no effect of Metaphor, F(1, 1,234) = 1.”
BackgroundInfluentialGangwar, R. S., Rajagopalan, S., Natarajan, R. D., & Deiuliis, J. A. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx197 · Cited by 98
Kracke, F., Lai, B., Yu, S., & Krömer, J. O. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.12.003 · Cited by 99
Genome editing of Ralstonia eutropha using an electroporation-based CRISPR-Cas9 technique
Xiong, B., Li, Z., Liu, L., Zhao, D., Zhang, X., & Bi, C. (2018) · Biotechnology for Biofuels · doi:10.1186/s13068-018-1170-4 · Cited by 95
Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats
Bäck, S., Necarsulmer, J., Whitaker, L. R., Coke, L. M., Koivula, P., Heathward, E. J., Fortuno, L. V., Zhang, Y., Yeh, C. G., Baldwin, H. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.035 · Cited by 91
Deng, H., Tan, S., Gao, X., Zou, C., Xu, C., Tu, K., Song, Q., Fan, F., Huang, W., & Zhang, Z. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.004 · Cited by 98
Gao, X., Jin, Z., Tan, X., Zhang, C., Zou, C., Zhang, W., Ding, J., Das, B. C., Severinov, K., Hitzeroth, I. I., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.045 · Cited by 96
Bell, D. R., Weber, J. K., Yin, W., Huynh, T., Duan, W., & Zhou, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913242117 · Cited by 90
“, primer in CRISPR (7, 8), siRNA in RNAi (9)], presents opportunities for designed RNA therapeutics, explaining why RNA aptamers have remained a popular area of research (4, 10).”
BackgroundInfluentialOral delivery of bacteria: Basic principles and biomedical applications
Li, S., Jiang, W., Zheng, C., Shao, D., Liu, Y., Huang, S., Han, J., Ding, J., Tao, Y., & Li, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.011 · Cited by 97
Nucleic Acid Based Constitutional Dynamic Networks: From Basic Principles to Applications
Yue, L., Wang, S., Zhou, Z., & Willner, I. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09891 · Cited by 96
Genetics and breeding for climate change in Orphan crops
Kamenya, S. N., Mikwa, E. O., Song, B., & Odeny, D. A. (2021) · Theoretical and Applied Genetics · doi:10.1007/s00122-020-03755-1 · Cited by 101
“2019) although the clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein-9 nuclease (Cas9) (CRISPR–Cas9) (Doudna and Charpentier 2014) is the most common.”
BackgroundThe fall of the innovation empire and its possible rise through open science
Gold, E. R. (2021) · Research Policy · doi:10.1016/j.respol.2021.104226 · Cited by 114
Gao, P., Lyu, Q., Ghanam, A. R., Lazzarotto, C. R., Newby, G. A., Zhang, W., Choi, M., Slivano, O. J., Holden, K., Walker, J. A., et al. (2021) · Genome Biology · doi:10.1186/s13059-021-02304-3 · Cited by 100
Fuller, C. W., Padayatti, P. S., Abderrahim, H., Adamiak, L., Alagar, N., Ananthapadmanabhan, N., Baek, J., Chinni, S., Choi, C., Delaney, K. J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112812119 · Cited by 98
Improvements in algal lipid production: a systems biology and gene editing approach
Banerjee, A., Banerjee, C., Negi, S., Chang, J.-S., & Shukla, P. (2018) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2017.1356803 · Cited by 92
“A recently emerged gene editing technology that has taken the world of molecular biology and biotechnology by storm is known as the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) CRISPR/Cas system [33,34] (Figure 3(a)).”
Transcription control engineering and applications in synthetic biology
Engstrom, M. D., & Pfleger, B. F. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.09.003 · Cited by 108
Intracellular Delivery of Nanomaterials via an Inertial Microfluidic Cell Hydroporator
Deng, Y., Kizer, M. E., Rada, M., Sage, J., Wang, X., Cheon, D., & Chung, A. J. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00704 · Cited by 99
Moro, D., Byrne, M. M., Kennedy, M. S., Campbell, S., & Tizard, M. L. (2018) · Global Ecology and Conservation · doi:10.1016/j.gecco.2017.e00363 · Cited by 131
Lao, Y., Li, M., Gao, M. A., Shao, D., Chi, C., Huang, D., Chakraborty, S., Ho, T., Jiang, W., Wang, H., et al. (2018) · Advanced Science · doi:10.1002/advs.201700540 · Cited by 101
Reprogramming the antigen specificity of B cells using genome-editing technologies
Voss, J. E., González-Martín, A., Andrabi, R., Fuller, R. P., Murrell, B., McCoy, L. E., Porter, K., Huang, D., Li, W., Sok, D., et al. (2019) · eLife · doi:10.7554/elife.42995 · Cited by 99
Off-Target Editing by CRISPR-Guided DNA Base Editors
Park, S., & Beal, P. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00573 · Cited by 97
Advanced mesoporous silica nanocarriers in cancer theranostics and gene editing applications
Živojević, K., Mladenović, M., Djisalov, M., Mundžić, M., Ruiz‐Hernández, E., Gadjanski, I., & Knežević, N. Ž. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.07.029 · Cited by 99
Molecular Mechanisms of Cutaneous Squamous Cell Carcinoma
Hedberg, M. L., Berry, C. T., Moshiri, A. S., Xiang, Y., Yeh, C. J., Atillasoy, C., Capell, B. C., & Seykora, J. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073478 · Cited by 108
Hassanien, A., Saadaoui, I., Schipper, K., Al-Marri, S., Dalgamouni, T., Aouida, M., Saeed, S., & Jabri, H. M. S. J. A. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1104914 · Cited by 100
“It offers an excellent time and labor efficient system (Doudna and Charpentier, 2014; Zhang et al., 2020) and multiple mitigation strategies succeeded in significantly reducing off-target effects (Han et al.”
BackgroundA Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220
Hou, P., Wu, C., Wang, Y., Qi, R., Bhavanasi, D., Zuo, Z., Santos, C. D., Chen, S., Chen, Y. Z., Zheng, H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1627 · Cited by 99
“Different versions of the guide RNA can be used to target Cas9 to specific sequences for genome engineering in cells as well as multicellular organisms (37,39,43).”
Zhu, P., Wu, F., Mosenson, J. A., Zhang, H., He, T., & Wu, W.-S. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.02.007 · Cited by 102
Wang, Y., Wang, Z., Chen, Y., Hua, X., Yu, Y., & Ji, Q. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.09.003 · Cited by 95
A direct-to-biology high-throughput chemistry approach to reactive fragment screening
Thomas, R. P., Heap, R. E., Zappacosta, F., Grant, E. K., Pogány, P., Besley, S., Fallon, D. J., Hann, M. M., House, D., Tomkinson, N. C. O., et al. (2021) · Chemical Science · doi:10.1039/d1sc03551g · Cited by 95
iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies
Palasantzas, V. E. J. M., Tamargo-Rubio, I., Le, K., Slager, J., Wijmenga, C., Jonkers, I. H., Kumar, V., Fu, J., & Withoff, S. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.01.002 · Cited by 86
CRISPR–Cas9 Gene Editing: Curing Genetic Diseases by Inherited Epigenetic Modifications
Kolanu, N. D. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1785234 · Cited by 113
Temperature effect on CRISPR-Cas9 mediated genome editing
Xiang, G., Zhang, X., An, C., Cheng, C., & Wang, H. (2017) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2017.03.004 · Cited by 100
“…et al., 2010), transcription activator-like effector nuclease (TALEN) (Bogdanove and Voytas, 2011), and clustered, regularly interspaced, short palindromic repeats/CRISPR-associated protein 9 (CRISPR-Cas9) (Doudna and Charpentier, 2014; Hsu et al., 2014) are invaluable tools for genome editing.”
BackgroundPosttransplant chimeric antigen receptor therapy
Smith, M. M., Zakrzewski, J. L., James, S. E., & Sadelain, M. (2018) · Blood · doi:10.1182/blood-2017-08-752121 · Cited by 99
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.